OverviewSuggest Edit
Eli Lilly and Company is a company that discovers, develops, manufactures, and markets pharmaceutical products. The company offers diabetes and endocrinology, immunology, neuroscience, oncology, and other products. Its products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals.
| Type | Public | |
| Founded | 1876 | |
| HQ | Indianapolis, IN, US | Map |
| Website | lilly.com | |
| Employee Ratings | More | |
| Overall Culture | A- | More |
Recent NewsAll News
- Thinking about trading options or stock in Eli Lilly, Pfizer, GameStop, Cleveland-Cliffs, or FuelCell Energy?
- Can The Rally Continue For Eli Lilly Stock After A 10% Rise On Increased Hopes For Its Alzheimer’s Drug
- Stocks making the biggest moves midday: Biogen, Eli Lilly and AMC
- Eli Lilly India gets nod for emergency use of antibody drugs combination for COVID-19
Key People/Management at Eli Lilly
David A. Ricks
Melissa Stapleton Barnes
Stephen F. Fry
Johna L. Norton
Myles O'Neill
Leigh Ann Pusey
Eli Lilly Office Locations
Eli Lilly Financials and Metrics
Eli Lilly Revenue
| USD | |
|---|---|
Revenue (Q1, 2021) | 6.8b |
Gross profit (Q1, 2021) | 4.9b |
Gross profit margin (Q1, 2021), % | 72.4% |
Net income (Q1, 2021) | 1.4b |
Market capitalization (11-Jun-2021) | 215.0b |
Closing stock price (11-Jun-2021) | 224.1 |
Cash (31-Mar-2021) | 3.0b |
EV | 228.2b |
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 1.2b | 957.5m | 2.1b | 4.2b | 5.6b | 6.8b | 1.5b | 2.9b | 4.1b | 1.4b |
Depreciation and Amortization | 422.8m | 848.0m | 1.3b | 356.5m | 603.9m | 891.9m | 273.6m | 598.0m | 956.4m | 350.3m |
Cash From Operating Activities | 436.5m | 2.0b | 4.1b | 311.3m | 1.4b | 2.9b | 382.4m | 2.9b | 4.7b | 1.7b |
Purchases of PP&E | (236.5m) | (546.5m) | (816.3m) | (203.7m) | (444.0m) | (707.4m) | (258.3m) | (540.1m) | (933.2m) | (300.3m) |
| USD | FY, 2017 |
|---|---|
Revenue/Employee | 562.6k |
Debt/Equity | 1.2 x |
Debt/Assets | 0.3 x |
Financial Leverage | 3.9 x |
Eli Lilly Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Disarm Therapeutics | October 15, 2020 | $135 m |
| Dermira | January 10, 2020 | $1.1 b |
| Loxo Oncology | January 07, 2019 | $6.92 b |
| AurKa Pharma | May 15, 2018 | $575 m |
| ARMO BioSciences Inc | May 11, 2018 | $1.6 b |
| CoLucid Pharmaceuticals | January 18, 2017 | $960 m |
| Novartis Animal Health | April 22, 2014 | $5.4 b |
| Lohmann Animal Health | February 24, 2014 | |
| ChemGen | January 24, 2012 | |
| Avid Radiopharmaceuticals | November 08, 2010 | $800 m |
Eli Lilly Revenue Breakdown
Eli Lilly revenue breakdown by geographic segment: 11.4% from Japan, 16.9% from Europe, 57.0% from United States and 14.7% from Other foreign countries
Eli Lilly Cybersecurity Score
Eli Lilly Environment, Social & Governance (ESG) Ratings
Eli Lilly Online and Social Media Presence
130.34k Twitter followers
Eli Lilly has 130.34k Twitter Followers. The number of followers has decreased 0.2% month over month and increased 1.7% quarter over quarter
Eli Lilly's Trends
Twitter Engagement Stats for @lillypad
22k
Tweets
1.3k
Following
130.3k
Followers
57
Tweets last 30 days
3.7
Avg. likes per Tweet
38.6%
Tweets with engagement
Eli Lilly Company Culture
Overall Culture
A-
73/100
CEO Rating
A-
74/100
Compensation
A
79/100
Diversity
C+
67/100
Eli Lilly News and Updates
Thinking about trading options or stock in Eli Lilly, Pfizer, GameStop, Cleveland-Cliffs, or FuelCell Energy?
Can The Rally Continue For Eli Lilly Stock After A 10% Rise On Increased Hopes For Its Alzheimer’s Drug
Stocks making the biggest moves midday: Biogen, Eli Lilly and AMC
Eli Lilly India gets nod for emergency use of antibody drugs combination for COVID-19
Global Animal Health Market (2021 to 2025) - Featuring Bayer, Eli Lilly and Zoetis Among Others
Global Insulin Pens, Syringes, Pumps and Injectors Market 2021-2030 with Novo Nordisk A/S, Eli Lilly and Co, Medtronic, Abbott, and Insulet Dominating
Eli Lilly Frequently Asked Questions
When was Eli Lilly founded?
Eli Lilly was founded in 1876.
Who are Eli Lilly key executives?
Eli Lilly's key executives are David A. Ricks, Melissa Stapleton Barnes and Stephen F. Fry.
How many employees does Eli Lilly have?
Eli Lilly has 33,625 employees.
What is Eli Lilly revenue?
Latest Eli Lilly annual revenue is $24.5 b.
What is Eli Lilly revenue per employee?
Latest Eli Lilly revenue per employee is $729.8 k.
Who are Eli Lilly competitors?
Competitors of Eli Lilly include Boehringer Ingelheim, Sanofi and Becton Dickinson.
Where is Eli Lilly headquarters?
Eli Lilly headquarters is located at 893 Delaware St, Indianapolis.
Where are Eli Lilly offices?
Eli Lilly has offices in Indianapolis, Branchburg, Cambridge, New York and in 36 other locations.
How many offices does Eli Lilly have?
Eli Lilly has 42 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies